Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
- PMID: 28783939
- PMCID: PMC5565079
- DOI: 10.9758/cpn.2017.15.3.282
Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
Abstract
Galactorrhea, as an adverse effect of psychotropic medications, usually develops due to high dose of antipsychotics. Selective serotonin reuptake inhibitors (SSRIs) have also been reported to be related to galactorrhea. To the best of our knowledge, no previous study reported galactorrhea with methylphenidate (MPH) use. Hereby, we report a case of an adolescent girl who developed galactorrhea after increasing his modifed-release oral MPH to 50 mg/day while under treatment of sertraline and very low dose haloperidol.
Keywords: Adolescent; Galactorrhea; Methylphenidate; Selective serotonin reuptake inhibitors.
References
-
- Almış BH, Almış H, Çelik M, Gümüştaş F, Turgut M. Methylphenidate induced gynecomastia in a prepubertal boy: a case report. Anadolu Psikiyatri Derg. 2016;17(Suppl 3):74–76. doi: 10.5455/apd.177010. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources